Dolnoslaski Szpital Specjalistyczny Im. T.Marciniaka-Centrum Medycyny Ratunkowej

At Dolnoslaski Szpital Specjalistyczny Im. T. Marciniaka-Centrum Medycyny Ratunkowej, clinical trials in nervous system diseases focus on acute ischemic stroke and related emergency care, including strategies to improve recovery and reduce disability after large-vessel occlusion.

• Testing whether mechanical thrombectomy adds benefit to standard treatment in patients with severe acute ischemic stroke
• Evaluating the safety of reperfusion therapy for stroke in people who were already taking oral anticoagulants
• Studying functional outcomes, survival, and overall neurological recovery after urgent stroke treatment

This research aims to refine emergency stroke care, improve patient outcomes, and support better treatment decisions in time-sensitive neurological conditions.

The site also conducts trials in cardiovascular diseases, with a strong emphasis on myocardial infarction, heart failure, and hypertrophic cardiomyopathy, exploring new ways to lower risk and improve long-term recovery.

• Assessing whether ziltivekimab can reduce major cardiovascular events after acute myocardial infarction
• Studying intravenous ferric carboxymaltose for patients with recent heart attack and iron deficiency
• Evaluating a new treatment approach for symptomatic obstructive hypertrophic cardiomyopathy

These studies are designed to test new therapies, improve cardiovascular risk reduction, and support recovery after serious heart-related events.

Research in immune system diseases at this hospital includes trials for giant cell arteritis, polymyalgia rheumatica, and Sjögren’s disease, with a focus on controlling inflammation and easing systemic symptoms.

• Comparing treatments for giant cell arteritis to help achieve steroid-free remission
• Studying dose adjustment needs in polymyalgia rheumatica when paired with a new anti-inflammatory therapy
• Evaluating therapies for Sjögren’s syndrome to reduce systemic disease activity and related complications

The research aims to improve treatment effectiveness, reduce reliance on long-term steroids, and better manage chronic inflammatory disease.

The trial portfolio also reflects broader specialization in musculoskeletal diseases, eye diseases, skin and connective tissue diseases, and stomatognathic diseases, alongside related immune system processes.

• Studying spinal muscular atrophy to understand whether a new therapy can improve motor function
• Supporting research that links immune-driven disease activity with symptoms across multiple organ systems
• Contributing to trials that broaden care options for rare and complex conditions

Overall, the research environment at Dolnoslaski Szpital Specjalistyczny Im. T. Marciniaka-Centrum Medycyny Ratunkowej combines emergency medicine expertise with studies aimed at testing innovative treatments and improving outcomes in both common and rare diseases.